The round was led by Regeneron Ventures, Innovation Endeavors, and Janus Henderson Investors with participation from T.A. Springer, CE-Ventures, MBX Capital, and YK Bioventures. Returning investors include AV8 Ventures, CU Innovations, and Buff Gold Ventures.

Think Bioscience is a privately held small molecule drug discovery company based in Boulder, Colorado. They are focused on developing therapeutics against targets that have historically been considered 'undruggable'. The company's team combines expertise in synthetic biology, protein biophysics, applied enzymology, computational chemistry, and medicinal chemistry to launch first-in-class program for diseases with high unmet need.